|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1988-11-3
|
|
pubmed:abstractText |
In a double-blind test it was shown the efficacy of topical fusidic acid in comparison with oral dicloxacillin, in patients with skin infection by Staphylococcus aureus or/and Streptococcus pyogenes. In the experimental group, 16 patients from 20 received 2% topical fusidic acid in cream and reacted well in a shorter period of time than 17 from a group of 20 that had 500 mg. of dicloxacillin orally twice a day.
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0210-5187
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
171-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:3050336-Administration, Oral,
pubmed-meshheading:3050336-Administration, Topical,
pubmed-meshheading:3050336-Adolescent,
pubmed-meshheading:3050336-Adult,
pubmed-meshheading:3050336-Dicloxacillin,
pubmed-meshheading:3050336-Female,
pubmed-meshheading:3050336-Fusidic Acid,
pubmed-meshheading:3050336-Humans,
pubmed-meshheading:3050336-Male,
pubmed-meshheading:3050336-Skin Diseases, Infectious,
pubmed-meshheading:3050336-Staphylococcal Skin Infections,
pubmed-meshheading:3050336-Staphylococcus aureus,
pubmed-meshheading:3050336-Streptococcal Infections,
pubmed-meshheading:3050336-Streptococcus pyogenes
|
|
pubmed:year |
1988
|
|
pubmed:articleTitle |
[Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
|
|
pubmed:affiliation |
Servicio de Dermatología, Universidad Nacional Autónoma de México.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Controlled Clinical Trial
|
